The Change in Paradigm for NSCLC Patients with EML4–ALK Translocation
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23137322
Abstract: The severe prognosis linked with a lung cancer diagnosis has changed with the discovery of oncogenic molecularly driven subgroups and the use of tailored treatment. ALK-translocated advanced lung cancer is the most interesting model, having… read more here.
Keywords: lung cancer; nsclc patients; patients eml4; change paradigm ... See more keywords